Taro Iwamoto

10PUBLICATIONS
45CO-AUTHORS
Rheumatology and arthritisInnate immunityDisease surveillanceAutoimmunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J).

|Aug 06, 2025
Rapid resolution of fever and panniculitis after anifrolumab in a patient with systemic lupus erythematosus refractory to standard immunosuppression.

Shunichiro Hanai, Yoshiaki Kobayashi, Taro Iwamoto

|Feb 22, 2024
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.

Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi

|Jan 26, 2024
Refractory systemic lupus erythematosus with neuropsychiatric manifestations successfully treated with anifrolumab.

Y Kobayashi, S Hanai, T Iwamoto

|Jan 12, 2024
Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.

Tomoaki Ida, Shunsuke Furuta, Michio Fujiwara

|Jul 17, 2023
Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database study.

Tomoaki Ida, Kei Ikeda, Hiroyuki Ohbe

Pageof 2

Frequent Collaborators

5 joint publications

Daiki Nakagomi

5 joint publications

Kei Ikeda

4 joint publications

Tomoaki Ida

4 joint publications

Hiroshi Nakajima